An open-label, proof-of-concept study assessing the effects of bromelain-based enzymatic debridement on biofilm and microbial loads in patients with venous leg ulcers and diabetic foot ulcers.

Saved in:
Bibliographic Details
Title: An open-label, proof-of-concept study assessing the effects of bromelain-based enzymatic debridement on biofilm and microbial loads in patients with venous leg ulcers and diabetic foot ulcers.
Authors: Snyder RJ; Barry University, Miami Shores, FL, USA., Singer AJ; Stony Brook University, Stony Brook, NY, USA., Dove CR; University of Texas, San Antonio, TX, USA., Heisler S; University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Petusevsky H; Barry University, Miami Shores, FL, USA., James G; Montana State University-Bozeman, Bozeman, MT, USA., deLancey Pulcini E; Montana State University-Bozeman, Bozeman, MT, USA., Yaakov AB; MediWound Ltd, Yavneh, Israel., Rosenberg L; MediWound Ltd, Yavneh, Israel., Grant E; DP Clinical VP, Biostatistics and Clinical Data Management, Rockville, MD, USA., Shoham Y; Ben-Gurion University of the Negev, Beersheba, Israel.
Source: Wounds : a compendium of clinical research and practice [Wounds] 2023 Dec; Vol. 35 (12), pp. E414-E419.
Publication Type: Journal Article
Journal Info: Publisher: HMP Global Country of Publication: United States NLM ID: 9010276 Publication Model: Print Cited Medium: Internet ISSN: 1943-2704 (Electronic) Linking ISSN: 10447946 NLM ISO Abbreviation: Wounds Subsets: MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first